novel virtual reality-based strategies for evaluating and ... · early schizophrenia • evaluate...
TRANSCRIPT
-
Click to edit Master subtitle style
Click to edit Master title style
George Foussias, MD PhD FRCPC VR & Behavioural Neuroscience Research Lab
Slaight Family Centre, Campbell Research Institute, and Schizophrenia Division, CAMH
Novel Virtual Reality-Based Strategies for Evaluating and Treating Negative Symptoms In Schizophrenia
-
Disclosures
No relevant disclosures
-
1. Mason et al. 1996; 2. Schooler 2006.
Cumulative Recovery Rates in First-Episode Schizophrenia2
Symptom remission Social functioning Full recovery
Per
cent
age
of s
ubje
cts
100
0 Year 3 Year 4 Year 5 Year 6
80
60
40
20
50
40
30
20
10
0 Year 0 Year 1 Year 2 Year 13
WHO-ISOS Social adjustment over 13 years1
Poor Fair Good
Functional Outcomes in Schizophrenia
-
Strauss et al. 2010; Sayers et al. 1996; Kiang et al. 2003; Faerden et al. 2009 & 2010; Fervaha et al. 2014; Foussias et al. 2009 & 2011; Konstantakopoulos
et al. 2011; Nakagami et al. 2008; Gard et al. 2007 & 2009.
Functional Outcomes in Schizophrenia
Motivation
Social Cognition
Neurocognition
Functional Outcomes
-
Waltz et al. 2007; Gold et al. 2008; Juckel et al. 2006; Gold et al. 2013; Fervaha et al. 2013; Barch et al. 2014; Treadway et al. 2014.
Objective Evaluations of Motivation in Schizophrenia
-
Animals At Work
-
Real-World Motivation Deficits in Schizophrenia
-
Demographics
SZ (n=50) Mean (SD)
HC (n=57) Mean (SD)
p Age 36.9 (10.6) 35.8 (11.6) ns Sex (M:F) 31:19 35:22 ns Duration of Illness (yrs) 13.6 (10.0)
Bivariate Correlations (rho)
Points Earned
Task Completions
Task Completion
Rate Amotivation (n=107) - .26** - .25** .29**
SZ Only (n=50) Amotivation - .29* - .41** .37** Positive symptoms - - - Diminished Expression - - - Depression - - - Anticipatory Pleasure - - - Consummatory Pleasure - - - Neurocognition - - - Motor speed - - - * p
-
Functional Neuroimaging in a Virtual Environment
• 3T GE scanner 6 x 5 min. runs MR-compatible
joystick
Demographics and Clinical Characteristics
SZ (n=18) Mean (SD)
HC (n=19) Mean (SD) p
Age 36.6 (11.3) 35.6 (12.7) ns Sex (M:F) 10:8 11:8 ns Diagnosis
Schizophrenia 16 Schizoaffective Disorder 2
Duration of Illness (yrs) 14.2 (8.6)
Positive symptoms (SAPS) 13.9 (3.0) Negative symptoms (SANS) 22.8 (8.3) 6.8 (6.4)
-
Striatal Function During Effortful Behavior
Subcortical ROI
Group Difference
s
Task Completio
ns (ρ) Effort Events
Accumbens - - Caudate - - Putamen - .40*
Reward Events Accumbens pcorr=.033 - Caudate pcorr=.066 - Putamen - .41*
* p
-
Whole Brain Functional Deficits in Effortful Behavior in SZ
Whole Brain Analysis
Coordinates
Beta-value Correlations (ρ)
Anatomic Region
x
y
z
Cluster size
Max T
SANS-Amotivation
Task Completions
Effort Events (HC>SZ)
E1
R Anterior Cingulate
18
38
32
357
4.12
-.37*
E2
L Medial Superior Frontal Gyrus
-6
30
46
196
4.1
-.56***
.39*
E3
L Inferior Frontal Gyrus
-52
26
16
121
4.05
-.47**
.35*
E4
R Angular Gyrus
40
-72
52
117
4.05
E5
L Middle Temporal Gyrus
-56
-72
16
160
3.97
-.37*
E6
L Angular Gyrus
-32
-56
34
196
3.76
-.34*
E7
R Cerebellum 6
32
-52
-30
181
3.73
-.34*
.38*
E8
R Cerebellum 6
14
-64
-20
121
3.69
-.45**
.40*
E9
R Inferior Frontal Gyrus
40
6
30
488
3.61
-.41*
.38*
E10
R Cerebellum Crus II
22
-78
-44
132
3.42
Reward Events (HC>SZ)
R1
R Mid Cingulate / Middle Frontal Gyrus
12
-6
32
492
5.53
R2
R Inferior Frontal Gyrus
50
36
20
159
4.87
.36*
R3
L Mid Cingulate
-6
0
28
263
4.34
R4
L Precentral Gyrus
-58
4
30
260
4.04
-.45**
R5
L Mid Cingulate
-8
20
38
178
3.87
* p
-
E2
E3
Functional Deficits in Effortful Behavior in SZ
-
E7 / E8
Functional Deficits in Effortful Behavior in SZ
-
E9
R2
Functional Deficits in Effortful Behavior in SZ
-
Antipsychotics
Antidepressants
CBT
Cognitive Remediation
Glutamatergic Agents
Stimulants
rTMS tDCS
Rummel et al. 2006; Murphy et al. 2006; Tuominen et al. 2006; Buckley et al. 2007; Singh et al. 2010
Treatments for Negative Symptoms
-
Computerized Brain Training
-
Game-Based and Virtual Therapy
Merry et al. 2012
PresenterPresentation NotesAnd translation to more engaging video games, with underlying CBT principles that show promise for effective treatment of depression in teens.Distinct modules, and text-based feedback and communication of underlying principles.Along with persistence of benefit (remission) beyond the end of treatment.
-
VR-based Treatment of Motivation Deficits
0
10
20
30
40
50
60
70
80
1 2 3 4 5
Effo
rt to
Rew
ard
Rat
io
Training Step
-
VR Rehabilitation for Motivation Deficits
Objective: • Pilot study to evaluate a VR-based treatment for motivation deficits in
early schizophrenia • Evaluate the secondary effects of VR-based motivation treatment on
community functioning
Participants • Schizophrenia or Schizoaffective Disorder • 18 – 35 years of age • Minimum Apathy Evaluation Scale (AES) score of 34 (moderate
motivation deficits)
Intervention • VR-based motivation training – 1hr per week x 8 weeks
-
VR Rehabilitation for Motivation Deficits
Participant Demographics
Mean (SD) at Baseline (n=15)
Age 25.3 (4.5)
Sex (M:F) 10:5
Positive symptoms (SAPS) 31.5 (16.9)
Negative symptoms (SANS) 41.1 (15.0)
Motivation Deficits (AES) 41.9 (4.8)
Cognition (BACS) -1.5 (0.9)
Depression (CDSS) 2.9 (2.5)
Community Functioning (QLS) 57.1 (14.8)
-
VR Rehabilitation for Motivation Deficits
* *
*
Significant reduction in motivation deficits F(4,45.7)=2.74, p=.04
Modest 9% improvement in motivation
27% increase in intrinsic motivation • 50% experiencing
>20% improvement
-
VR Rehabilitation for Motivation Deficits
Baseline Mean (SD)
Post-treatment Mean (SD) t p
Intrinsic Motivation (QLS) 20.1 (6.1) 24.2 (4.0) -2.9 0.014
Community Functioning (QLS) 54.9 (15.8) 64.6 (13.7) -1.94 0.079
Interpersonal Functioning (QLS) 22.3 (9.9) 22.0 (8.4) 0.16 ns
Instrumental Functioning (QLS) 5.8 (5.0) 9.6 (7.0) -2.41 0.035
Positive Symptoms (SAPS) 36.4 (14.8) 30.9 (20.2) 2.61 0.024
Depression (CDSS) 3.1 (2.5) 3.2 (3.4) -0.12 ns
Cognition (BACS) -1.7 (0.9) -1.7 (1.1) 0.19 ns
-
VR Rehabilitation for Motivation Deficits
* 56% improvement in role
functioning
50% of patients experienced > 20% improvement
-
VR Rehabilitation for Motivation Deficits
-
Acknowledgements
Gary Remington Albert Wong Martin Lepage Konstantine Zakzanis Paul Fletcher Ishraq Siddiqui Gagan Fervaha Sarah Saperia Susana Da Silva John Zawadzki Krysta McDonald Areti Apatsidou
Aristotle N. Voineskos Colin Hawco Joseph Viviano Research participants
-
Thank you
Slide Number 1DisclosuresFunctional Outcomes in SchizophreniaFunctional Outcomes in SchizophreniaObjective Evaluations of Motivation in SchizophreniaAnimals At WorkReal-World Motivation Deficits in SchizophreniaSlide Number 8Functional Neuroimaging in a Virtual EnvironmentSlide Number 10Striatal Function During Effortful BehaviorWhole Brain Functional Deficits in Effortful Behavior in SZSlide Number 13Slide Number 14Slide Number 15Treatments for Negative SymptomsComputerized Brain TrainingGame-Based and Virtual TherapyVR-based Treatment of Motivation DeficitsVR Rehabilitation for Motivation DeficitsVR Rehabilitation for Motivation DeficitsVR Rehabilitation for Motivation DeficitsVR Rehabilitation for Motivation DeficitsVR Rehabilitation for Motivation DeficitsVR Rehabilitation for Motivation DeficitsAcknowledgementsThank you